Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine
Reference52 articles.
1. European Commission. Estimates of cancer incidence and mortality in 2020, for all countries. Eur Com (2020). Online access on 2 April 2021. https://ecis.jrc.ec.europa.eu/explorer.php?$0-1$1-All$2-All$4-1,2$3-0$6-0,85$5-2004,2010$7-2$CRatesByRegistry$X0_10-ASR_EU_NEW
2. Thompson IM, Tangen CM, Paradelo J et al (2009) Adjuvant radiotherapy for pathologic T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol 181(3):956–962. https://doi.org/10.1016/j.juro.2008.11.032
3. Bolla M, van Poppel H, Tombal B, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, van Velthoven R, Colombel M, van de Beek C, Verhagen P, van den Bergh A, Sternberg C, Gasser T, van Tienhoven G, Scalliet P, Haustermans K, Collette L (2012) Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911). Lancet 380(9858):2018–27 (Epub 2012 Oct 19)
4. Wiegel T, Bartkowiak D, Bottke D, Bronner C, Steiner U, Siegmann A, Golz R, Störkel S, Willich N, Semjonow A, Stöckle M, Rübe C, Rebmann U, Kälble T, Feldmann HJ, Wirth M, Hofmann R, Engenhart-Cabillic R, Hinke A, Hinkelbein W, Miller K (2014) Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96–02/AUO AP 09/95 trial. Eur Urol 66(2):243–250. https://doi.org/10.1016/j.eururo.2014.03.011 (Epub 2014 Mar 21)
5. Arcangeli S, Ramella S, De Bari B, Franco P, Alongi F, D’Angelillo RM (2016) A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective. Crit Rev Oncol Hematol 97:322–7. https://doi.org/10.1016/j.critrevonc.2015.09.005 (Epub 2015 Oct 9)
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献